Skip to main content
SpringerLink
Log in

The Role of Opioid Analgesics in Rheumatoid Disease in the Elderly Population

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Adequate pain therapy is an important aspect in the treatment of the elderly patient with rheumatoid disease. Problems with traditional NSAIDs include potentially serious gastrointestinal, cardiovascular and renal adverse effects, especially in the elderly. In addition, the selective cyclo-oxygenase-2 inhibitors have been associated with renal and cardiovascular adverse effects which may limit their use in the elderly with renal or cardiovascular disease.

Opioids provide a treatment option for the management of pain in elderly patients with rheumatoid disease in whom pain control under standard management is poor; however, various therapeutic difficulties are encountered in the heterogenous elderly population (increased risk of adverse effects, multimorbidity, and polypharmacy). Lower initial opioid dosage, prolonged dosage intervals and slower dosage titrations are advisable because of altered pharmacokinetics and pharmacodynamics. Kidney function should be tightly monitored and a timely use of laxatives is to be encouraged.

Randomised clinical studies of opioids in musculoskeletal pain (e.g. osteoarthritis) have increasingly extended the scientific basis for their use. However, no randomised controlled clinical trials have examined the efficacy and the benefit/risk ratio of opioids in rheumatoid arthritis.

Opioids also demonstrate an analgesic effect following local peripheral application. This opens the way to new therapeutic options in the future through the development of systemic peripherally selective opioids without CNS adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24

    Article  PubMed  CAS  Google Scholar 

  2. Anderson KO, Bradley LA, Turner RA, et al. Pain behavior of rheumatoid arthritis patients enrolled in experimental drug trials. Arthritis Care Res 1994; 7: 64–8

    Article  PubMed  CAS  Google Scholar 

  3. Skevington S. Psychological aspects of pain in rheumatoid arthritis: a review. Soc Sci Med 1986; 23: 567–75

    Article  PubMed  CAS  Google Scholar 

  4. Buckelew SP, Parker JC. Coping with arthritis pain: a review of the literature. Arthritis Care Res 1989; 2: 136–45

    Article  PubMed  CAS  Google Scholar 

  5. Creamer P, Hochberg MC. Osteoarthritis. Lancet 1997; 350: 503–8

    Article  PubMed  CAS  Google Scholar 

  6. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41(5): 778–99

    Article  PubMed  CAS  Google Scholar 

  7. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view of prevention. Arthritis Rheum 1998; 41(8): 1343–55

    Article  PubMed  CAS  Google Scholar 

  8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46(2): 328–46

    Article  Google Scholar 

  9. Johnson AG, Day RO. The problems and pitfalls of NSAID therapy in the elderly (Part 1). Drugs Aging 1991; 1(2): 130–43

    Article  PubMed  CAS  Google Scholar 

  10. Wolfe MM, Lichtenstein D, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888–99

    Article  PubMed  CAS  Google Scholar 

  11. Singh G, Triadafilopoulus G. Epidemiology of NSAID-induced gastrointestinal complications. J Rheumatol 1999; 26Suppl. 56: 18–24

    Google Scholar 

  12. Tramer MR, Moore RA, Reynolds DJ, et al. Quantitative estimation of rare adverse events which follow biological progression: a new model applied to chronic NSAID use. Pain 2000; 85(1–2): 169–82

    Article  PubMed  CAS  Google Scholar 

  13. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114(4): 257–63

    PubMed  CAS  Google Scholar 

  14. Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104(3A): 23S–9S

    Article  PubMed  CAS  Google Scholar 

  15. Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114(9): 753–40

    Google Scholar 

  16. Griffin MR, Yared A, Ray WA. Nonsteroidal anti-inflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000; 151(5): 488–96

    Article  PubMed  CAS  Google Scholar 

  17. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med 2000; 160(6): 777–84

    Article  PubMed  CAS  Google Scholar 

  18. Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998; 158(10): 1108–12

    Article  PubMed  CAS  Google Scholar 

  19. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The class study: a randomized controlled trial. JAMA 2000; 284: 1247–55

    Article  PubMed  CAS  Google Scholar 

  20. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrotintestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520–8

    Article  PubMed  CAS  Google Scholar 

  21. Whelton A, Fort JG, Puma JA, et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001; 8(2): 85–95

    Article  PubMed  CAS  Google Scholar 

  22. Swan SK, Rudy DW, Lasseter KC, et al. Effect of cycloox-ygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: a randomized, controlled trial. Ann Intern Med 2000; 133(1): 1–9

    PubMed  CAS  Google Scholar 

  23. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121(4): 289–300

    PubMed  CAS  Google Scholar 

  24. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000; 43(2): 378–85

    Article  PubMed  CAS  Google Scholar 

  25. Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990; 5 (1 Suppl.): 46–62

    Article  Google Scholar 

  26. Schug SA. Opioids for chronic noncancer pain. Pain Clinical Updates IASP 1995; III(3): 1–7

    Google Scholar 

  27. Graven S, de Vet HCW, van Kleef M, et al. Opioids in chronic nonmalignant pain: a criteria-based review of the literature. In: Devor M, Roubotham MC, Wiesnfeld-Hallin, editors. Proceedings of the 9th World Congress on Pain; 1999; Vienna, Austria. Seattle (WA): IASP Press, 2000: 965–72

    Google Scholar 

  28. Stein C. What is wrong with opioids in chronic pain? Curr Opin Anaesthesiol 2000; 13: 557–9

    Article  PubMed  CAS  Google Scholar 

  29. Roth SH. Arthritis therapy: a better time, a better day [editorial]. Rheumatology 2001; 40: 603–6

    Article  PubMed  CAS  Google Scholar 

  30. American Geriatrics Society Panel on Chronic Pain in Older Persons. Clinical practice guidelines: the management of chronic pain in older persons. J Am Geriatr Soc 1998; 46(5): 635–51

    Google Scholar 

  31. Ferrell BR, Ferrell BA, editors. Pain in the elderly. Seattle (WA): IASP Press, 1996

    Google Scholar 

  32. Gagliese L, Melzack R. Chronic pain in elderly people. Pain 1997; 70(1): 3–14

    Article  PubMed  CAS  Google Scholar 

  33. Gloth FM. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 2001; 49(2): 188–99

    Article  PubMed  Google Scholar 

  34. Weiner DK. Improving pain management for older adults: an urgent agenda for the educator, investigator, and practitioner. Pain 2002; 97(1–2): 1–4

    Article  PubMed  Google Scholar 

  35. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. SAGE Study Group: systematic assessment of geriatric drug use via epidemiology. JAMA 1998; 279(23): 1877–82

    Article  PubMed  CAS  Google Scholar 

  36. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330(9): 592–6

    Article  PubMed  CAS  Google Scholar 

  37. Harkins SW, Price DD. Assessment of pain in the elderly. In: Turk DC, Melzack R, editors. Handbook of pain assessment: New York: Guilford, 1992: 315–31

    Google Scholar 

  38. Wright GE, Parker JC, Smarr KL, et al. Age, depressive symptoms, and rheumatoid arthritis. Arthritis Rheum 1998; 41: 298–305

    Article  PubMed  CAS  Google Scholar 

  39. Davis GC, Cortex C, Rubin BR. Pain management in the older adult with rheumatoid arthritis or osteoarthritis. Arthritis Care Res 1990; 3(3): 127–31

    PubMed  CAS  Google Scholar 

  40. Gibson SJ, Farrell MJ, Katz B, et al. Multidisciplinary management of chronic non-malignant pain on older adults. In: Ferrell BR, Ferrell BA, editors. Pain in the elderly. Seattle (WA): IASP Press, 1996: 91–99

    Google Scholar 

  41. Ross MM, Crook J. Elderly recipients of home nursing services: pain, disability and functional competence. J Adv Nurs 1998; 27(6): 1117–26

    Article  PubMed  CAS  Google Scholar 

  42. Watkins KW, Shifren K, Park DC, et al. Age, pain and coping with rheumatoid arthritis. Pain 1999; 82: 217–28

    Article  PubMed  CAS  Google Scholar 

  43. Macintyre PE, Jarvis DA. Age is the best predictor of postoperative morphine requirements. Pain 1995; 64: 357–64

    Article  Google Scholar 

  44. Kaiko RF. Age and morphine analgesia in cancer patients with postoperative pain. Clin Pharmacol Ther 1980; 28: 823–6

    Article  PubMed  CAS  Google Scholar 

  45. Bentley JB, Borel JD, Nenad Jr RE, et al. Age and fentanyl pharmacokinetics. Anesth Analg 1982; 61(12): 968–71

    Article  PubMed  CAS  Google Scholar 

  46. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240: 159–66

    PubMed  CAS  Google Scholar 

  47. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315(7115): 1059

    Article  PubMed  CAS  Google Scholar 

  48. Forman WB, Stratton M. Current approaches to chronic pain in older patients. Geriatrics 1991; 46: 47–52

    PubMed  CAS  Google Scholar 

  49. Portenoy RK, Farkash A. Practical management of non-malignant pain in the elderly. Geriatrics 1988; 43: 29–47

    PubMed  CAS  Google Scholar 

  50. Bellville JW, Forrest WH, Miller E, et al. Influence of age on pain relief from analgesics. JAMA 1971; 217: 1835–41

    Article  PubMed  CAS  Google Scholar 

  51. Loick G, Radbruch L, Sabatowski R, et al. Morphine dose and side effects: a comparison of older and younger patients with tumour pain [in German]. Dtsch Med Wochenschr 2000 Oct 13; 125(41): 1216–21

    Article  PubMed  CAS  Google Scholar 

  52. Portenoy RK. Optimal pain control in elderly cancer patients. Geriatrics 1987; 42: 33–44

    PubMed  CAS  Google Scholar 

  53. Vigano A, Buera E, Suarez-Almazor ME. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 1998; 83: 1244–50

    Article  PubMed  CAS  Google Scholar 

  54. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 1999; 19(1): 88–93

    Article  PubMed  CAS  Google Scholar 

  55. Evans PJS. Opioids for chronic musculoskeletal pain. In: Kalso E, McQuay JH, Wiesenfeld-Hallin Z, editors. Opioid sensitivity of chronic noncancer pain: progress in pain research and management. Vol. 14. Seattle (WA): IASP Press, 1999: 349–65

    Google Scholar 

  56. Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study. Arthritis Rheum 1999; 42(7): 1370–7

    Article  PubMed  CAS  Google Scholar 

  57. Moulin DE, Iezzi A, Amireh R, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347(8995): 143–7

    Article  PubMed  CAS  Google Scholar 

  58. Arkinstall W, Sandler A, Goughnour B, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995; 62(2): 169–78

    Article  PubMed  CAS  Google Scholar 

  59. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: a double-blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999; 26(4): 862–9

    PubMed  CAS  Google Scholar 

  60. Peloso PM, Bellamy N, Bensen W, et al. Double blind randomize placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000; 27(3): 764–71

    PubMed  CAS  Google Scholar 

  61. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000; 160(6): 853–60

    Article  PubMed  CAS  Google Scholar 

  62. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13: 6–8

  63. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998; 41(9): 1603–12

    Article  PubMed  CAS  Google Scholar 

  64. Gelfand SG. Opioids and rheumatic disease pain: comment on the article by Ytterberg, et al. Arthritis Rheum 1999; 42(4): 830–1

    Article  PubMed  CAS  Google Scholar 

  65. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50(6): 1837–41

    Article  PubMed  CAS  Google Scholar 

  66. McQuay H. Opioids in chronic non-malignant pain. BMJ 2001; 322(7295): 1134–5

    Article  PubMed  CAS  Google Scholar 

  67. American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Practice guidelines for chronic pain management. Anesthesiology 1997; 86: 995–1004

    Article  Google Scholar 

  68. Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheuamatoid arthritis. Cochrane Database Syst Rev 2003; (1): CD000189

    Google Scholar 

  69. WHO. Cancer pain relief. 2nd ed. Geneva: WHO, 1996

    Google Scholar 

  70. Fishman SM, Bandman TB, Edwards A, et al. The opioid contract in the management of chronic pain. J Pain Symptom Manage 1999; 18: 27–37

    Article  PubMed  CAS  Google Scholar 

  71. Roth SH. Efficacy and safety of tramadol HCL in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998; 25(7): 1358–63

    PubMed  CAS  Google Scholar 

  72. Pavelka K, Peliskova Z, Stehlikova H, et al. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Invest 1998; 16: 421–9

    Article  CAS  Google Scholar 

  73. Wilder-Smith CH, Hill L, Spargo K, et al. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: a randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001; 91(1–2): 23–31

    Article  PubMed  CAS  Google Scholar 

  74. Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322(7295): 1154–8

    Article  PubMed  CAS  Google Scholar 

  75. Schaefer M. Peripheral opioid analgesia: from experimental to clinical studies. Curr Opin Anaesthesiol 1999; 12: 603–11

    Article  Google Scholar 

  76. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332(25): 1685–90

    Article  PubMed  CAS  Google Scholar 

  77. Zhou L, Zhang Q, Stein C, et al. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 1998; 286(2): 1000–6

    PubMed  CAS  Google Scholar 

  78. Schaefer M, Imai Y, Uhl GR, et al. Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmaol 1995; 279(2–3): 165–9

    Article  CAS  Google Scholar 

  79. Gupta A, Bodin L, Holmström B, et al. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 2001; 93(9): 761–70

    Article  PubMed  CAS  Google Scholar 

  80. Likar R, Schaefer M, Paulak F, et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 1997; 84(6): 1313–7

    PubMed  CAS  Google Scholar 

  81. Stein A, Yassoouridis A, Szopko C, et al. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999; 83(3): 525–32

    Article  PubMed  CAS  Google Scholar 

  82. Stein C, Pfluger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996; 98(3): 793–9

    Article  PubMed  CAS  Google Scholar 

  83. Rozental JD, Sculco TP. Intra-articular corticosteroids: an updated overview. Am J Orthop 2000; 29: 18–23

    PubMed  CAS  Google Scholar 

  84. Barber A, Bartoszyk GD, Bender HM, et al. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br J Pharmacol 1994; 113(4): 1317–27

    Article  PubMed  CAS  Google Scholar 

  85. Walker JS. Anti-inflammatory effects of opioids. Adv Exp Med Biol 2003; 521: 148–60

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University Erlangen-Nürnberg, Krankenhausstraße 12, Erlangen, 91054, Germany

    Norbert Griessinger

  2. Department of Anesthesiology and Critical Care Medicine, Benjamin Franklin University Hospital, Free University of Berlin, Berlin, Germany

    Reinhard Sittl & Michael Schaefer

  3. Department of Anesthesiology and Intensive Medicine, General Hospital Klagenfurt, Klagenfurt, Austria

    Robert Jost & Rudolf Likar

Authors
  1. Norbert Griessinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reinhard Sittl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Jost
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rudolf Likar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norbert Griessinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griessinger, N., Sittl, R., Jost, R. et al. The Role of Opioid Analgesics in Rheumatoid Disease in the Elderly Population. Drugs Aging 20, 571–583 (2003). https://doi.org/10.2165/00002512-200320080-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200320080-00003

Keywords

Search

Navigation